Skip to Content

Illumina Inc ILMN Stock Quote

| Rating as of


Morningstar‘s Stock Analysis ILMN

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


No Fair Value Estimate Change as Illumina Trims 2022 Outlook Again but Order Book Impresses

Julie Utterback Senior Equity Analyst

Analyst Note

| Julie Utterback |

Narrow-moat genomic sequencing leader Illumina turned in third-quarter financial results that were slightly better than expected. However, given external challenges and its own new product pipeline cannibalizing sales, the firm trimmed its outlook for 2022. At first glance, we are maintaining our fair value estimate, and we think investors with a long-term horizon should view any share weakness as an opportunity.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics ILMN

Company Profile ILMN

Business Description

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

5200 Illumina Way
San Diego, CA, 92122
Industry Diagnostics & Research
Employees 11,750

Related Articles ILMN

FAQs for Illumina Inc Stock

No. ILMN does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

ILMN’s market cap is 32.80 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

ILMN’s stock style is Large Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

ILMN’s price/sales is 6.97.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

ILMN’s price/forward earnings is 72.99.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

ILMN’s price/book is 4.87.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See ILMN’s valuation ratios compared to the Market Index.

ILMN’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare ILMN’s historical performance against its industry peers and the overall market.